**Question:** The mass treatment of trachoma is undetermined if the prevalence in the community is:

A. less than 5%
B. between 5% and 10%
C. greater than or equal to 10%
D. not mentioned

**Core Concept:** In trachoma control programs, the prevalence of the disease is used as a basis for deciding on the need for mass drug administration (MDA) with antibiotics to prevent transmission and reduce morbidity. Trachoma is a bacterial infection caused by Chlamydia trachomatis, which affects the conjunctiva and results in inflammation and scarring of the eyelids.

**Why the Correct Answer is Right:** The World Health Organization (WHO) recommends MDA if the prevalence of active trachoma (follicular trachoma) is greater than or equal to 10% in children aged 1-9 years. This threshold ensures that the community is at risk of maintaining a high enough infection rate to maintain transmission, leading to the continued cycle of infection and disease progression.

**Why Each Wrong Option is Incorrect:**

A. Less than 5%: This choice is incorrect because a prevalence rate below 5% indicates the community is at low risk for maintaining the transmission of the infection and intervention may not be necessary.

B. Between 5% and 10%: This choice is also incorrect as the WHO guidelines recommend intervention when the prevalence is greater than or equal to 10%.

D. Not mentioned: This option is irrelevant as it does not specify a prevalence threshold for initiating MDA.

**Clinical Pearl:** Trachoma control programs should aim to reach a prevalence of less than 5% in the community to prevent the need for mass drug administration, ensuring that the infection rate is low enough to interrupt transmission and halt the progression of the disease.

**Correct Answer:** C. greater than or equal to 10%